SCHEMBL19254545

SCHEMBL19254545

CCN(C/C=C\c1ccccc1S(=O)(=O)Nc1ccc2c(c1C(=O)O)CCCC2)CCOC(C)S

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12022091 0.94 METAP2 (0.81) METAP2
SCHEMBL12037940 0.90 METAP2 (0.84) METAP2
SCHEMBL21017472 0.89 METAP2 (0.83) METAP2
SCHEMBL3986691 0.88 METAP2 (1.00) METAP2
SCHEMBL3986694 0.88 METAP2 (1.00) METAP2
SCHEMBL3988213 0.88 METAP2 (1.00) METAP2
SCHEMBL19880254 0.88 METAP2 (0.81) METAP2
SCHEMBL16176014 0.88 METAP2 (1.00) METAP2
SCHEMBL3979227 0.84 METAP2 (1.00) METAP2
SCHEMBL3982013 0.84 METAP2 (1.00) METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9730955-B2 Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof SYNDEVRX, INC. (US) 2017-08-15 US disclosed